Retinitis Pigmentosa and Netra Restoration Therapy
Retinitis Pigmentosa, often abbreviated RP, is a group of inherited retinal dystrophies in which the light-sensing cells of the retina gradually lose function over time. The condition most often begins with difficulty seeing at night, followed by progressive loss of peripheral vision. Many patients describe the later stage as tunnel vision. Central vision may remain useful for many years in some patients, while others experience earlier involvement of reading vision, contrast sensitivity, light sensitivity, color perception, or cystoid macular changes.
The National Eye Institute describes RP as a group of rare genetic eye diseases that affect the retina and cause retinal cells to break down slowly over time. NEI also notes that RP usually begins with night vision and peripheral vision loss, and that the condition is genetically linked to many different genes and inheritance patterns. This genetic diversity helps explain why two patients with the same broad diagnosis may have very different rates of progression, retinal imaging patterns, visual field loss, and daily visual challenges.
Netra Restoration Therapy, or NRT, approaches Retinitis Pigmentosa from a full-spectrum integrative ophthalmology perspective. NRT does not claim to alter a patient's genetic mutation, cure RP, or replace retinal monitoring, genetic counseling, low-vision rehabilitation, or urgent eye evaluation when symptoms change. Instead, NRT is designed to support the biological terrain in which the remaining retinal cells must function. In RP, that terrain includes photoreceptor metabolism, retinal pigment epithelium support, ocular blood flow, oxidative stress, inflammatory balance, mitochondrial function, neurotrophin signaling, tissue oxygenation, retinal circulation, gut-retina immune signaling, and whole-body metabolic resilience.
A helpful way to understand RP is to separate the initiating cause from the modifying terrain. The initiating cause is usually genetic. However, the speed and pattern of degeneration may be influenced by multiple downstream biological pathways. Modern RP literature has repeatedly discussed oxidative stress, metabolic stress, inflammation, autophagy dysfunction, mitochondrial dysfunction, vascular changes, trophic factor deficiency, endoplasmic reticulum stress, apoptosis, necroptosis, ferroptosis-related lipid damage, and cone vulnerability after rod loss. These pathways do not replace genetics; they help explain why inherited retinal degeneration can become a progressive systems problem inside the retina.